Selected Publications
Nacarelli T, Fukumoto T, Zundell JA, Fatkhutdinov N, Jean S, Cadungog MG, Borowsky ME, Zhang R: NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer. Cancer Res 80(4):890-900 : 2020.
Karakashev S, Fukumoto T, Zhao B, Lin J, Wu S, Fatkhutdinov N, Park PH, Semenova G, Jean S, Cadungog MG, Borowsky ME, Kossenkov AV, Liu Q, Zhang R: EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition. Cancer Cell 37(2):157-167.e6 : 2020.
Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, Abate-Shen CT, Zhang R: ARID1A promotes genomic stability through protecting telomere cohesion. Nat Commun 10(1):4067 : 2019.
Fukumoto T, Zhu H, Nacarelli T, Karakashev S, Fatkhutdinov N, Wu S, Liu P, Kossenkov AV, Showe LC, Jean S, Zhang L, Zhang R: N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance. Cancer Res 79(11):2812-2820 : 2019.
Singha B, Harper SL, Goldman AR, Bitler BG, Aird KM, Borowsky ME, Cadungog MG, Liu Q, Zhang R, Jean S, Drapkin R, Speicher DW: CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer. Sci Rep 8(1):14725 : 2018.
Fukumoto T, Park P, Wu S, Fatkhutdinov N, Karakashev S, Nacarelli T, Kossenkov AV, Speicher DW, Jean S, Zhang L, Wang T, Shih I, Conejo-Garcia JR, Bitler BG, Zhang R: Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep 22(13):3393-3400 : 2018.
George E, Kim H, Krepler C, Wenz B, Makvandi M, Tanyi JL, Brown E, Zhang R, Brafford P, Jean S, Mach RH, Lu Y, Mills GB, Herlyn M, Morgan M, Zhang X, Soslow R, Drapkin R, Johnson N, Zheng Y, Cotsarelis G, Nathanson KL, Simpkins F: A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers. JCI Insight 2(1):e89760 : 2017.
Jean S, Li J, Katsaros D, Wubbenhorst B, Maxwell KN, Fishbein L, Mclane MW, Benedetto C, Canuto EM, Mitra N, Zhang L, Nathanson KL, Tanyi, JL: Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. Oncotarget 7(30):48577-48585 : 2016.
Jean S, Li J, Wubbenhorst B, Maxwell KN, Fishbein L, Mclane MW, Mitra N, Zhang L, Nathanson KL, Tanyi, JL: Paclitaxel is necessary for improved survival in epithelial ovarian cancers with somatic homologous recombination gene mutations. Abstract presented, American Association for Cancer Research Annual Meeting, Washington, DC : 2015.
Jean S, Marsh EB and Chu CS: Gynecology. The Surgical Review: An Integrated Basic and Clinical Science Study Guide, 4th Edition Chapter 28 : 2015.
Academic Contact Information
Abramson Cancer Center West Chester
440 E. Marshall Street, Suite 101
West Chester,
PA
19380
Phone: 631-793-3697
Patient appointments: 800-789-7366